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1.1. A library revealing orally bioavailable tubulin polymerase
inhibitors
Microtubule-targeting agents (MTAs) comprise a class of anti-
cancer compounds that have shown clinical success in a range of
cancer types. The drugs bind to heterodimers of a- and b-tubulin
and consequently interfere with natural microtubule function.
MTAs can either stabilise or destabilise microtubules, but the result
either way is disruption of cell function leading to apoptosis. Sev-
eral drugs that work as binders to microtubules suffer from some
signiﬁcant disadvantages. For example, drug resistance or adverse
toxicities can prove dose-limiting. Thus, there is still an ongoing
search for new MTAs, and towards this end, a recent paper
describes the synthesis of a library of indole-3-glyoxylamide










The new library of compounds focussed initially on removing
the chlorophenyl sidechain with a particular aim of increasing
the count of sp3 carbon atoms as such changes are known to
improve the solubility of small molecules. The tubulin polymerisa-
tion inhibitors identiﬁed from this study were investigated in mod-
els of head and neck cancer (HNC) where existing MTAs have
shown beneﬁt.
The glyoxylamides were derived from N-substituted indoles by
one of two routes. N-substituted indoles (2) were reacted with
oxalyl chloride and then amines to generate the amide products
(3). However, as this route proved to be unsatisfactory for indoles
substituted on positions 4 to 7, these indoles (4) were reacted
under Friedel–Crafts conditions with aluminium chloride to give
glyoxalate ester intermediates (5) which were then reacted with






























The library compounds prepared by these methods were ﬁrst
assessed for cytotoxicity against FaDu, an HNC cell line derived
from a squamous cell carcinoma from the larynx. LC50 values were
derived for compounds showing cytotoxicity at or below 10 lM at
the 72 h time point. In particular it was found that alkyl groups on
the indole nitrogen were generally lacking in activity unless the
glyoxylamide derivative contained a methoxypyridine group (e.g.



















The study examined variation in several positions around the
glyoxylamide structure, making over 60 compounds in total and
these compounds were additionally proﬁled in solubility, microso-
mal stability and CACO-2 permeability assays. A subset of
compounds was chosen for evaluation in a tubulin polymerisation
assay, and several were found to suppress polymerisation in a
dose-dependent manner. Ultimately two compounds were
selected for an in vivo efﬁcacy study in a mouse HNC model
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LC50 values below 100 nM and a microsomal half-life exceeding
30 min. Mice were dosed orally with compound 8 at 10 mg/kg
daily for 10 days over which time there was a signiﬁcant reduction
in tumour growth relative to the control group.
Overall, this study has used a library synthesis of indole-3-gly-
oxylamides to ﬁnd compounds which are inhibitors of tubulin
polymerisation, that show cancer cell toxicity, and were active in
a mouse xenograft model. Although improvements in pharmacoki-
netics are still required, the compounds reveal a new SAR pattern
that might lead to the discovery of MTA compounds with improved
activity and potential clinical efﬁcacy.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
A solid-phase synthesis procedure for the parallel preparation
of 6,7-cycloalkane-fused 1,4-diazepane-2,5-diones has been
described. The methodology applied a- and alicyclic b-amino acid
building blocks to construct the seven-membered heterocyclic
core, while alcohols were used for further skeletal decoration.
The use of a cyclisation/release strategy permitted the isolation
of the target cyclic a,b-dipeptides in good purities and generally
moderate to good yields. A 26-membered model library has been
reported and NMR spectroscopic data used to describe the overall
conformational behaviour of the obtained homodiketopiperazines
[2].
2.2. Solution-phase synthesis
The synthesis of novel 7-amino-substituted pyrazolo[1,5-a]
[1,3,5]triazine-8-carbonitriles has been achieved via a three-com-
ponent reaction of 3-amino-substituted 5-aminopyrazole-4-car-
bonitriles, cyanamide and triethyl orthoformate under
microwave irradiation. Under catalyst-free conditions, this three-
component reaction accommodated a generous diversity of amino
substituents making it ideal for the generation of compound
libraries for drug discovery processes [3].
An efﬁcient and concise synthesis of structurally diverse thia-
zolo[3,2-a]chromeno[4,3-d]pyrimidin-6(7H)-one derivatives in
good to excellent yields has been developed. This reaction is a ver-
satile one-pot multicomponent condensation of 4-hydroxy-
coumarins, 2-aminobenzothiazoles, and various aldehydes
catalysed by eco-friendly and reusable 1-butyl-3-methylimida-
zolium tetraﬂuoroborate ionic liquid under solvent-free condi-
tions. Several advantages of this protocol include operational
simplicity, short reaction time, efﬁcient utilisation of the reactants,
non-chromatographic puriﬁcation procedure, wide functional
group tolerance, and ease of recovery and reuse of the catalyst
for at least ﬁve consecutive cycles without loss of activity [4].
2.3. Scaffolds and synthons for combinatorial libraries
A new methodology has been developed for the synthesis of
hexahydro-1H-pyrido[2,3-b]indol-2-one scaffolds via a sequential
Michael addition/amidation/reductive cyclisation process. A wide
variety of products bearing a hexahydro-1H-pyrido[2,3-b]indol-2-
one core with varying degrees of substitution around it were
obtained smoothly with high efﬁciency (up to overall yield of
67%). Furthermore, biological activities have been preliminarily
demonstrated by in vitro evaluation against human prostate cancer
cells PC-3, human lung cancer cells A549 and human leukemia
cells K562 using MTT-based assays. The results demonstrated that
many compounds showed considerable cytotoxicities against
these three cell lines, and that hexahydro-1H-pyrido[2,3-b]indol-2-one scaffolds may be potential leads for further antitumour
activity screenings [5].
2.4. Solid-phase supported reagents
Various primary and secondary alcohols have been selectively
oxidised to the corresponding aldehydes and ketones using silica
supported TEMPO as a heterogeneous catalyst and nitrosonium
tetraﬂuoroborate as a cocatalyst. No over-oxidation of aldehydes
to acids, nitration processes or oxidation of double bonds was
observed. The reported procedure is very convenient, and uses
mild experimental conditions (room temperature and dioxygen
as the terminal oxidant). Furthermore, the reactions proceeded
cleanly and isolation of the desired compounds required minimal
work-up [6].
A simple, highly efﬁcient and environmentally benign method
for the synthesis of pyrrolo[1,2-a]quinoxalines has been developed
using a green and recyclable catalyst, Amberlite IR-120H resin
under solvent-free conditions. The method provides several advan-
tages such as mild conditions, no use of oxidant, and an environ-
mentally compatible and inexpensive catalyst. Moreover, the
catalyst can be recovered after completion of the reaction and
can be reused as the catalytic property of the resin is not affected
even up to ﬁve cycles [7].
The catalytic activity of palladium supported on magnetic
nanoparticles in the amination coupling reaction of different nitro-
gen containing substrates with aryl halides has been investigated.
C–N bond formation was achieved in moderate to excellent yields
and the catalyst could be separated by magnetic decantation [8].
A ligand-free Pd/Al(OH)3 nano-catalyst which has been pre-
pared by a one-pot three-component method using Pd(PPh3)4,
tetra(ethylene glycol), and aluminium tri-sec-butoxide has exhib-
ited excellent catalytic activity in Stille cross-couplings of (het)aryl
chlorides, arenediazonium tetraﬂuoroborate salts with phenyl-
tributylstannane, respectively, and Kumada couplings of (het)aryl
chlorides with various Grignard reagents. More importantly, these
two processes have shown excellent functional group compatibil-
ity with moderate to good yields and they are also versatile with
respect to not only (het)aryl chlorides, but also diazonium salts,
and heteroaryl Grignard reagents. The nano-catalyst could also
be recycled and reused ﬁve times without loss of activity or
decrease of yield [9].
2.5. Novel resins, linkers and techniques
Side-chain to side-chain lactam-bridged cyclic peptides have
been used as therapeutic agents and biochemical tools. An efﬁcient
microwave-assisted synthesis of side-chain to side-chain lactam-
bridge cyclic peptides has been reported. The synthesis time and
efforts are signiﬁcantly reduced with this method, and it avoids
side product formation. Analytical and pharmacological data of
the synthesised cyclic peptides are in accordance with the com-
mercially obtained compounds. This new method could be used
to synthesise other side-chain to side-chain lactam-bridge pep-
tides and amenable to automation and extensive SAR compound
derivatisation [10].
2.6. Library applications
A novel molecular framework with a lysine core has been
explored to prepare a probe library for protein kinases. Active
site-directed probes, identiﬁed through screening of the library,
displayed desirable labelling properties, including target speci-
ﬁcity, good linear response to the corresponding enzymatic activity
and cell permeability. Finally, a two-stage protocol utilising the
newly developed probe with an immunoprecipitation step was
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in RK3E-v-Src cells [11].
A library of triazole-based analogues of bromotyramine
alkaloids such as verongamines, hemibastadins, pseudoceramine
D and clavatidine E has been designed in order to identify
promising leads that may help in the control of bacterial bioﬁlms.
Twenty-three compounds were screened for their bioﬁlm
inhibitory activity against three strains of Gram-negative bacteria.
SAR studies revealed that hemibastadin analogues were the most
active compounds which act as inhibitors of bioﬁlm development
(EC50 8.8–29 lM) without effect on bacterial growth even at high
concentrations (100 lM) [12].
N-Aryl derivatives of edaravone have been identiﬁed as poten-
tially effective small molecule inhibitors of tau and beta-amyloid
aggregation in the context of developing disease-modifying thera-
peutics for Alzheimer’s disease. Palladium-catalysed hydrazine
monoarylation protocols have been employed as an expedient
means of preparing a focussed library of 21 edaravone derivatives
featuring varied N-aryl substitution, enabling structure–activity
relationship studies. On the basis of data obtained from two func-
tional biochemical assays examining ﬁbril and oligomer formation,
it was determined that derivatives featuring an N-biaryl motif
were fourfold more potent than edaravone [13].
BACE-1 (b-secretase) is considered to be a promising targets for
treatment of Alzheimer’s disease as it catalyses the rate limiting
step of Ab-42 production. A novel class of allylidene hydrazinecar-
boximidamide derivatives have been disclosed as moderately
potent BACE-1 inhibitors, having aminoguanidine substitution on
an allyl linker with two aromatic groups on either side. A library
of derivatives was designed based on the docking studies, synthe-
sised and evaluated for BACE-1 inhibition in vitro [14].
The synthesis and SAR studies that led to the discovery of
benzamide (reverse amide) as potent and selective human
b3-adrenergic receptor agonists has been described. Based on a
conformationally restricted pyrrolidine scaffold, a pyrrolidine ben-
zoic acid intermediate was previously synthesised, and from
library synthesis and further optimisation efforts, several struc-
turally diverse reverse amides were found to have excellent human
b3-adrenergic potency and good selectivity over the b1 and b2
receptors [15].
Diversity-oriented construction of new indolizine scaffolds has
been accomplished by employing domino Knoevenagel condensa-
tion/intramolecular aldol cyclisation reactions. Biological evalua-
tion revealed anticancer activity of these compounds through
inhibition of b-catenin and activation of p53 [16].
A novel and green approach for the synthesis of 2-substituted
benzothiazole analogues has been reported. A number of 2-aryl
and heteroaryl benzothiazole scaffolds were synthesised using
Amberlite IR-120 resin under microwave irradiation. The catalytic
role and reusability of the resin has been fully described and 2-sub-
stituted benzothiazole analogues were also tested against several
bacterial strains (Staphylococcus aureus, Escherichia coli, Bacillus
subtilis, Salmonella) and cancer cell lines (MCF-7 and HeLa) [17].
Antimitotic agents are widely used in cancer chemotherapy but
the numerous side effects and the onset of resistance limit their
clinical efﬁcacy. With the purpose of discovering more selective
and efﬁcient anticancer agents to be administered alone or in com-
bination with traditional drugs, a large library of 1,3,4-thiadiazo-
line analogues has been synthesised. This library maintained the
pharmacophoric structure of an antiproliferative compound
known as K858;a new kinesin Eg5 inhibitor, able to induce the
mitotic arrest in colorectal cancer cells and in xenograft ovarian
cancer cells. 103 compounds were screened to assess their antipro-
liferative activity on a PC3 prostate cancer cell line [18].
A recent study involved the synthesis and lead structure
selection of the best anti-leukemic agent from a library of aza-podophyllotoxin analogues (APTs). A scalable, modiﬁed multicom-
ponent reaction has been reported that uses a ‘sacriﬁcial’ aniline
partner as a more general route to rapidly construct the pivotal
library of 50 APT analogues. Preliminary structure activity relation-
ship studies for anti-leukemic activity also addressed the innate
toxicity of these compounds against non-malignant cells. Two
novel compounds were discovered to be more potent than etopo-
side, having high selectivity against the human THP-1 leukemia
cell line and a minimal toxicity [19].
A new library of phenothiazine and 1,3,4-thiadiazole hybrid
derivatives has been designed based on themolecular hybridisation
approach and the molecules were synthesised in excellent yields
using a facile single-step chloro-amine coupling reaction between
2-chloro-1-(10H-phenothiazin-10-yl)ethanones and 2-amino-5-
subsituted-1,3,4-thiadiazoles. The compounds were evaluated for
their in vitro inhibition activity against Mycobacterium tuberculosis
H37Rv [20].References
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